dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:45:40Z
dc.date.available2014-05-20T13:45:40Z
dc.date.created2014-05-20T13:45:40Z
dc.date.issued1999-08-28
dc.identifierBrain Research. Amsterdam: Elsevier B.V., v. 839, n. 2, p. 227-234, 1999.
dc.identifier0006-8993
dc.identifierhttp://hdl.handle.net/11449/16073
dc.identifier10.1016/S0006-8993(99)01695-9
dc.identifierWOS:000082449000003
dc.identifier1023597870118105
dc.description.abstractThe effect of noradrenaline, and mixed ligands to alpha(2)-adrenoceptors (alpha(2)-AR) and imidazoline receptors (IR), injected intracerebroventricularly (i.c.v.), on sodium intake of sodium depleted rats, was tested against idazoxan, a mixed antagonist ligand to alpha(2)-AR and IR. The inhibition of sodium intake induced by noradrenaline (80 nmol) was completely reversed by idazoxan (160 and 320 nmol) injected i.c.v. The inhibition of sodium intake induced by mixed ligands to alpha(2)-AR and IR, UK14,304, guanabenz and moxonidine, was antagonized from 50 to 60% by idazoxan i.c.v. The results demonstrate that noradrenaline, a non-ligand for IR, acts on alpha(2)-AR inhibiting sodium intake. The possibility that either alpha(2)-AR or IR mediate the effect of mixed agonists on sodium intake remains an open question. (C) 1999 Elsevier B.V. B.V. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationBrain Research
dc.relation3.125
dc.relation1,404
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectadrenergic
dc.subjectimidazoline
dc.subjectsodium appetite
dc.subjectwater intake
dc.subjectdehydration
dc.titleNoradrenaline and mixed alpha(2)-adrenoceptor/imidazoline-receptor ligands: effects on sodium intake
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución